Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

MLA

Mahlangu, Johnny, et al. “Phase 3 Study of Recombinant Factor VIII Fc Fusion Protein in Severe Hemophilia A.” Blood, vol. 123, no. 3, Jan. 2014, pp. 317–25. EBSCOhost, https://doi.org/10.1182/blood-2013-10-529974.

APA

Mahlangu, J., Powell, J. S., Ragni, M. V., Chowdary, P., Josephson, N. C., Pabinger, I., Hanabusa, H., Gupta, N., Kulkarni, R., Fogarty, P., Perry, D., Shapiro, A., Pasi, K. J., Apte, S., Nestorov, I., Jiang, H., Li, S., Neelakantan, S., Cristiano, L. M., … Pierce, G. F. (2014). Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood, 123(3), 317–325. https://doi.org/10.1182/blood-2013-10-529974

Chicago

Mahlangu, Johnny, Jerry S Powell, Margaret V Ragni, Pratima Chowdary, Neil C Josephson, Ingrid Pabinger, Hideji Hanabusa, et al. 2014. “Phase 3 Study of Recombinant Factor VIII Fc Fusion Protein in Severe Hemophilia A.” Blood 123 (3): 317–25. doi:10.1182/blood-2013-10-529974.